Literature DB >> 12647814

The pathological basis of myocardial hibernation.

N G Frangogiannis1.   

Abstract

Myocardial hibernation refers to a state of persistent regional ventricular dysfunction, in patients with coronary artery disease that is reversible with revascularization. It is part of the spectrum of pathophysiological responses to myocardial ischemia and is a particularly important concept in understanding the development and progression of ischemic cardiomyopathy. Hibernating myocardium may be associated with chronic hypoperfusion, or result from repetitive episodes of ischemia with a cumulative effect on contractile function. Mechanistic studies on myocardial hibernation have been hampered by the difficulty in developing a reproducible and reliable animal model. This review describes the pathologic changes found in hibernating myocardial segments discussing the potential mechanisms involved in their development. Depletion of cardiomyocyte contractile elements, loss of myofilaments and disorganization of cytoskeletal proteins are among the most consistently reported morphological alterations found in hibernating myocardial segments. In addition, the cardiac intersitium exhibits inflammatory changes, leading to fibrotic remodeling. Induction of cytokines and chemokines suggests an active continuous inflammatory process leading to fibrosis and dysfunction. Although, the initial response may be adaptive to ischemia, if timely revascularization is not performed, irreversible tissue injury, fibrosis and myocyte degeneration may develop. Understanding the role of inflammatory mediators in the development and progression of the cardiomyopathic process may lead to the development of specific therapeutic strategies aiming at preventing irreversible fibrosis and dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 12647814     DOI: 10.14670/HH-18.647

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging.

Authors:  Mingkai Yun; Binbin Nie; Wanwan Wen; Ziwei Zhu; Hua Liu; Shaoping Nie; Rupert Lanzenberger; Yongxiang Wei; Marcus Hacker; Baoci Shan; Heinrich R Schelbert; Xiang Li; Xiaoli Zhang
Journal:  J Nucl Cardiol       Date:  2020-07-20       Impact factor: 5.952

4.  Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein.

Authors:  Li Lei; Steve Mason; Dinggang Liu; Yan Huang; Carolyn Marks; Reed Hickey; Ion S Jovin; Marc Pypaert; Randall S Johnson; Frank J Giordano
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

5.  Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

Authors:  R H J A Slart; R A Tio; P A van der Vleuten; T P Willems; D D Lubbers; R A Dierckx; D J van Veldhuisen
Journal:  J Nucl Cardiol       Date:  2010-03-18       Impact factor: 5.952

6.  Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity.

Authors:  Geeta D Thakker; Nikolaos G Frangogiannis; Pawel T Zymek; Saumya Sharma; Joe L Raya; Philip M Barger; Heinrich Taegtmeyer; Mark L Entman; Christie M Ballantyne
Journal:  Obesity (Silver Spring)       Date:  2008-10-02       Impact factor: 5.002

7.  Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.

Authors:  Suvi E Heinonen; Mari Merentie; Marja Hedman; Petri I Mäkinen; Elina Loponen; Ivana Kholová; Fatima Bosch; Markku Laakso; Seppo Ylä-Herttuala
Journal:  Cardiovasc Diabetol       Date:  2011-06-30       Impact factor: 9.951

8.  Septic cardiomyopathy: evidence for a reduced force-generating capacity of human atrial myocardium in acute infective endocarditis.

Authors:  Katja Buschmann; Ryan Chaban; Anna Lena Emrich; Marwan Youssef; Angela Kornberger; Andres Beiras-Fernandez; Christian Friedrich Vahl
Journal:  Innov Surg Sci       Date:  2017-04-13

9.  A spatially-distributed computational model to quantify behaviour of contrast agents in MR perfusion imaging.

Authors:  A N Cookson; J Lee; C Michler; R Chabiniok; E Hyde; D Nordsletten; N P Smith
Journal:  Med Image Anal       Date:  2014-07-18       Impact factor: 8.545

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.